Global Facial injectables Market: Industry Analysis and forecast (2019 to 2026): By Type, treatment, End User, and Region

Global Facial injectables Market: Industry Analysis and forecast (2019 to 2026): By Type, treatment, End User, and Region

Market Scenario

Global Facial injectables Market was valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2026, at CAGR of 12.1 % during forecast period of 2019 to 2026. Global Facial injectables Market Facial injectable products also known as dermal Fillers. These are the products which help in facial rejuvenation. The facial injectable products are mostly used to treat the early signs of ageing such as wrinkles thereby increasing the aesthetic beauty. Global Facial injectables Market Drivers and Restrains Factors such as rising aesthetic consciousness and number of cosmetic procedures, introduction of cost-effective facial injectable and aging population are expected to drive the global Facial injectable Market during the forecast period. Moreover, changing market scenario in healthcare sector because of drug discovery & product launch is expected to fuel the global Facial injectables Market in forecast period. Strict regulatory concerns of injectable products and side effects of such products such as rashes and itching sensation are considered to be the major restraint to global Facial injectables Market. Global Facial injectable Market key segmentation By Type, Polymer fillers are further segmented into polymethylmethacrylate beads and poly-L-lactic acid. Collagen injectables are used for the treatment of wrinkles, laugh lines, creases, lip border restoration, facial rejuvenation, face contouring and acne scars. The collagen segment is anticipated to have favorable market growth over the forecast period because of the increasing use of collagen in facial injectables to correct facial skin imperfections. Dermatology clinics will witness significant growth opportunities over the period heading to increasing patient pool for facial treatments. Availability of skilled professionals specialized in dermal treatments such as fillers and injectable are responsible for this segmental growth. Global Facial injectable Market Regional Analysis North America was the most dominating market for facial injectables in 2018. Factors such as organized regulatory framework and reimbursement scenarios are further assisting the facial injectables market in North America and where responsible for this market growth. According to International Society of Aesthetic Plastic Surgery (ISAPS), U.S. holds the largest number of facial filling procedures carried out all over the world. Asia-Pacific is anticipated as the fastest growing market during the forecast period. Rising disposable income, awareness regarding aesthetic and plastic surgeries in the regions, especially in the countries such as India, South Korea and China are driving the facial injectables market in Asia-Pacific. Moreover, rapidly developing healthcare infrastructure and booming entertainment industry would further boost the growth of facial injectables market in Asia-Pacific. The objective of the report is to present comprehensive analysis of Global Facial injectable Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Facial injectable Market dynamics, structure by analyzing the market segments, and project the Global Facial injectable Market size. Clear representation of competitive analysis of key players by Facial injectable Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Facial injectable Market make the report investor’s guide.

Global Facial injectable Market by type

• Collagen • Hyaluronic Acid (HA) • Botulin Toxin Type A • Calcium Hydroxyapatite (Catha) • Polymer Fillers

Global Facial injectable Market by treatment

• Facial Pain • Wrinkle Treatment • Acne scar treatment • Lip Augmentation • Lipoatrophy treatment • Others (chin augmentation and Earlobe rejuvenation)

Global Facial injectable Market by end user

• Hospitals • Ambulatory Surgical Centers • Cosmetic Centers • Dermatology Clinics • Physician Clinics

Global Facial injectable Market by Region

• Asia Pacific • North America • Europe • Latin America • Middle East Africa

Key players operating on Global Facial injectable Market

• Bloomage BioTechnology Corporation Limited, • Ipsen Group, • Allergan Plc, • Prollenium Medical Technologies Inc., • Galderma S.A. (Nestle), and • Merz Pharma & Co. KGaA. • Advanced Dermatology • ColBar LifeScience Ltd., , • Valeant Pharmaceuticals North America LLC, • Sano Biosurgery Inc., • Anika Therapeutics, Inc.

Table of Contents

Global Facial injectables Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Facial injectables Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Facial injectables Market Analysis and Forecast 6.1. Global Facial injectables Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Facial injectables Market Analysis and Forecast, by Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Facial injectables Market Value Share Analysis, by Type 7.4. Global Facial injectables Market Size (US$ Bn) Forecast, by Type 7.5. Global Facial injectables Market Analysis, by Type 7.6. Global Facial injectables Market Attractiveness Analysis, by Type 8. Global Facial injectables Market Analysis and Forecast, by Treatment 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Facial injectables Market Value Share Analysis, by Treatment 8.4. Global Facial injectables Market Size (US$ Bn) Forecast, by Treatment 8.5. Global Facial injectables Market Analysis, by Treatment 8.6. Global Facial injectables Market Attractiveness Analysis, by Treatment 9. Global Facial injectables Market Analysis and Forecast, by End-use 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Facial injectables Market Value Share Analysis, by End-use 9.4. Global Facial injectables Market Size (US$ Bn) Forecast, by End-use 9.5. Global Facial injectables Market Analysis, by End-use 9.6. Global Facial injectables Market Attractiveness Analysis, by End-use 10. Global Facial injectables Market Analysis, by Region 10.1. Global Facial injectables Market Value Share Analysis, by Region 10.2. Global Facial injectables Market Size (US$ Bn) Forecast, by Region 10.3. Global Facial injectables Market Attractiveness Analysis, by Region 11. North America Facial injectables Market Analysis 11.1. Key Findings 11.2. North America Facial injectables Market Overview 11.3. North America Facial injectables Market Value Share Analysis, by Type 11.4. North America Facial injectables Market Forecast, by Type 11.4.1. Collagen 11.4.2. Hyaluronic Acid (HA) 11.4.3. Botulinum Toxin Type A 11.4.4. Calcium Hydroxylapatite (CaHA) 11.4.5. Polymer Fillers 11.5. North America Facial injectables Market Value Share Analysis, by Treatment 11.6. North America Facial injectables Market Forecast, by Treatment 11.6.1. Facial Pain 11.6.2. Wrinkle Treatment 11.6.3. Acne scar treatment 11.6.4. Lip Augmentation 11.6.5. Lipoatrophy treatment 11.6.6. Others (chin augmentation and Earlobe rejuvenation) 11.7. North America Facial injectables Market Value Share Analysis, by End-use 11.8. North America Facial injectables Market Forecast, by End-use 11.8.1. Hospitals, 11.8.2. Ambulatory Surgical Centers, 11.8.3. Cosmetic Centers, 11.8.4. Dermatology Clinics, 11.8.5. Physician Clinic 11.9. North America Facial injectables Market Value Share Analysis, by Country 11.10. North America Facial injectables Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Facial injectables Market Analysis, by Country 11.12. U.S. Facial injectables Market Forecast, by Type 11.12.1. Collagen 11.12.2. Hyaluronic Acid (HA) 11.12.3. Botulinum Toxin Type A 11.12.4. Calcium Hydroxylapatite (CaHA) 11.12.5. Polymer Fillers 11.13. U.S. Facial injectables Market Forecast, by Treatment 11.13.1. Facial Pain 11.13.2. Wrinkle Treatment 11.13.3. Acne scar treatment 11.13.4. Lip Augmentation 11.13.5. Lipoatrophy treatment 11.13.6. Others (chin augmentation and Earlobe rejuvenation) 11.14. U.S. Facial injectables Market Forecast, by End-use 11.14.1. Hospitals, 11.14.2. Ambulatory Surgical Centers, 11.14.3. Cosmetic Centers, 11.14.4. Dermatology Clinics, 11.14.5. Physician Clinics 11.15. Canada Facial injectables Market Forecast, by Type 11.15.1. Collagen 11.15.2. Hyaluronic Acid (HA) 11.15.3. Botulinum Toxin Type A 11.15.4. Calcium Hydroxylapatite (CaHA) 11.15.5. Polymer Fillers 11.16. Steel Canada Facial injectables Market Forecast, by Treatment 11.16.1. Facial Pain 11.16.2. Wrinkle Treatment 11.16.3. Acne scar treatment 11.16.4. Lip Augmentation 11.16.5. Lipoatrophy treatment 11.16.6. Others (chin augmentation and Earlobe rejuvenation) 11.17. Canada Facial injectables Market Forecast, by End-use 11.17.1. Hospitals, 11.17.2. Ambulatory Surgical Centers, 11.17.3. Cosmetic Centers, 11.17.4. Dermatology Clinics, 11.17.5. Physician Clinics 11.18. North America Facial injectables Market Attractiveness Analysis 11.18.1. By Type 11.18.2. By Treatment 11.18.3. By End-use 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Facial injectables Market Analysis 12.1. Key Findings 12.2. Europe Facial injectables Market Overview 12.3. Europe Facial injectables Market Value Share Analysis, by Type 12.4. Europe Facial injectables Market Forecast, by Type 12.4.1. Collagen 12.4.2. Hyaluronic Acid (HA) 12.4.3. Botulinum Toxin Type A 12.4.4. Calcium Hydroxylapatite (CaHA) 12.4.5. Polymer Fillers 12.5. Europe Facial injectables Market Value Share Analysis, by Treatment 12.6. Europe Facial injectables Market Forecast, by Treatment 12.6.1. Facial Pain, 12.6.2. Wrinkle Treatment, 12.6.3. Lip Augmentation 12.7. Europe Facial injectables Market Value Share Analysis, by End-use 12.8. Europe Facial injectables Market Forecast, by End-use 12.8.1. Hospitals, 12.8.2. Ambulatory Surgical Centers, 12.8.3. Cosmetic Centers, 12.8.4. Dermatology Clinics, 12.8.5. Physician Clinics 12.9. Europe Facial injectables Market Value Share Analysis, by Country 12.10. Europe Facial injectables Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Facial injectables Market Analysis, by Country 12.12. Germany Facial injectables Market Forecast, by Type 12.12.1. Collagen 12.12.2. Hyaluronic Acid (HA) 12.12.3. Botulinum Toxin Type A 12.12.4. Calcium Hydroxylapatite (CaHA) 12.12.5. Polymer Fillers 12.13. Germany Facial injectables Market Forecast, by Treatment 12.13.1. Facial Pain, 12.13.2. Wrinkle Treatment, 12.13.3. Lip Augmentation Facial Pain 12.13.4. Wrinkle Treatment 12.13.5. Acne scar treatment 12.13.6. Lip Augmentation 12.13.7. Lipoatrophy treatment 12.13.8. Others (chin augmentation and Earlobe rejuvenation) 12.14. Germany Facial injectables Market Forecast, by End-use 12.14.1. Hospitals, 12.14.2. Ambulatory Surgical Centers, 12.14.3. Cosmetic Centers, 12.14.4. Dermatology Clinics, 12.14.5. Physician Clinics 12.15. U.K. Facial injectables Market Forecast, by Type 12.15.1. Collagen 12.15.2. Hyaluronic Acid (HA) 12.15.3. Botulinum Toxin Type A 12.15.4. Calcium Hydroxylapatite (CaHA) 12.15.5. Polymer Fillers 12.16. U.K. Facial injectables Market Forecast, by Treatment 12.16.1. Facial Pain, 12.16.2. Wrinkle Treatment, 12.16.3. Lip Augmentation 12.17. U.K. Facial injectables Market Forecast, by End-use 12.17.1. Hospitals, 12.17.2. Ambulatory Surgical Centers, 12.17.3. Cosmetic Centers, 12.17.4. Dermatology Clinics, 12.17.5. Physician Clinics 12.18. France Facial injectables Market Forecast, by Type 12.18.1. Collagen 12.18.2. Hyaluronic Acid (HA) 12.18.3. Botulinum Toxin Type A 12.18.4. Calcium Hydroxylapatite (CaHA) 12.18.5. Polymer Fillers 12.19. France Facial injectables Market Forecast, by Treatment 12.19.1. Facial Pain 12.19.2. Wrinkle Treatment 12.19.3. Acne scar treatment 12.19.4. Lip Augmentation 12.19.5. Lipoatrophy treatment 12.19.6. Others (chin augmentation and Earlobe rejuvenation) 12.20. France Facial injectables Market Forecast, by End-use 12.20.1. Hospitals, 12.20.2. Ambulatory Surgical Centers, 12.20.3. Cosmetic Centers, 12.20.4. Dermatology Clinics, 12.20.5. Physician Clinics 12.21. Italy Facial injectables Market Forecast, by Type 12.21.1. Collagen 12.21.2. Hyaluronic Acid (HA) 12.21.3. Botulinum Toxin Type A 12.21.4. Calcium Hydroxylapatite (CaHA) 12.21.5. Polymer Fillers 12.22. Italy Facial injectables Market Forecast, by Treatment 12.22.1. Facial Pain 12.22.2. Wrinkle Treatment 12.22.3. Acne scar treatment 12.22.4. Lip Augmentation 12.22.5. Lipoatrophy treatment 12.22.6. Others (chin augmentation and Earlobe rejuvenation) 12.23. Italy Facial injectables Market Forecast, by End-use 12.23.1. Hospitals, 12.23.2. Ambulatory Surgical Centers, 12.23.3. Cosmetic Centers, 12.23.4. Dermatology Clinics, 12.23.5. Physician Clinics 12.24. Spain Facial injectables Market Forecast, by Type 12.24.1. Collagen 12.24.2. Hyaluronic Acid (HA) 12.24.3. Botulinum Toxin Type A 12.24.4. Calcium Hydroxylapatite (CaHA) 12.24.5. Polymer Fillers 12.25. Spain Facial injectables Market Forecast, by Treatment 12.25.1. Facial Pain 12.25.2. Wrinkle Treatment 12.25.3. Acne scar treatment 12.25.4. Lip Augmentation 12.25.5. Lipoatrophy treatment 12.25.6. Others (chin augmentation and Earlobe rejuvenation) 12.26. Spain Facial injectables Market Forecast, by End-use 12.26.1. Hospitals, 12.26.2. Ambulatory Surgical Centers, 12.26.3. Cosmetic Centers, 12.26.4. Dermatology Clinics, 12.26.5. Physician Clinics 12.27. Rest of Europe Facial injectables Market Forecast, by Type 12.27.1. Collagen 12.27.2. Hyaluronic Acid (HA) 12.27.3. Botulinum Toxin Type A 12.27.4. Calcium Hydroxylapatite (CaHA) 12.27.5. Polymer Fillers 12.28. Rest of Europe Facial injectables Market Forecast, by Treatment 12.28.1. Facial Pain 12.28.2. Wrinkle Treatment 12.28.3. Acne scar treatment 12.28.4. Lip Augmentation 12.28.5. Lipoatrophy treatment 12.28.6. Others (chin augmentation and Earlobe rejuvenation) 12.29. Rest Of Europe Facial injectables Market Forecast, by End-use 12.29.1. Hospitals, 12.29.2. Ambulatory Surgical Centers, 12.29.3. Cosmetic Centers, 12.29.4. Dermatology Clinics, 12.29.5. Physician Clinics 12.30. Europe Facial injectables Market Attractiveness Analysis 12.30.1. By Type 12.30.2. By Treatment 12.30.3. By End-use 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Facial injectables Market Analysis 13.1. Key Findings 13.2. Asia Pacific Facial injectables Market Overview 13.3. Asia Pacific Facial injectables Market Value Share Analysis, by Type 13.4. Asia Pacific Facial injectables Market Forecast, by Type 13.4.1. Collagen 13.4.2. Hyaluronic Acid (HA) 13.4.3. Botulinum Toxin Type A 13.4.4. Calcium Hydroxylapatite (CaHA) 13.4.5. Polymer Fillers 13.5. Asia Pacific Facial injectables Market Value Share Analysis, by Treatment 13.6. Asia Pacific Facial injectables Market Forecast, by Treatment 13.6.1. Facial Pain 13.6.2. Wrinkle Treatment 13.6.3. Acne scar treatment 13.6.4. Lip Augmentation 13.6.5. Lipoatrophy treatment 13.6.6. Others (chin augmentation and Earlobe rejuvenation) 13.7. Asia Pacific Facial injectables Market Value Share Analysis, by End-use 13.8. Asia Pacific Facial injectables Market Forecast, by End-use 13.8.1. Hospitals, 13.8.2. Ambulatory Surgical Centers, 13.8.3. Cosmetic Centers, 13.8.4. Dermatology Clinics, 13.8.5. Physician Clinics 13.9. Asia Pacific Facial injectables Market Value Share Analysis, by Country 13.10. Asia Pacific Facial injectables Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Facial injectables Market Analysis, by Country 13.12. China Facial injectables Market Forecast, by Type 13.12.1. Collagen 13.12.2. Hyaluronic Acid (HA) 13.12.3. Botulinum Toxin Type A 13.12.4. Calcium Hydroxylapatite (CaHA) 13.12.5. Polymer Fillers 13.13. China Facial injectables Market Forecast, by Treatment 13.13.1. Facial Pain 13.13.2. Wrinkle Treatment 13.13.3. Acne scar treatment 13.13.4. Lip Augmentation 13.13.5. Lipoatrophy treatment 13.13.6. Others (chin augmentation and Earlobe rejuvenation) 13.14. China Facial injectables Market Forecast, by End-use 13.14.1. Hospitals, 13.14.2. Ambulatory Surgical Centers, 13.14.3. Cosmetic Centers, 13.14.4. Dermatology Clinics, 13.14.5. Physician Clinics 13.15. India Facial injectables Market Forecast, by Type 13.15.1. Collagen 13.15.2. Hyaluronic Acid (HA) 13.15.3. Botulinum Toxin Type A 13.15.4. Calcium Hydroxylapatite (CaHA) 13.15.5. Polymer Fillers 13.16. India Facial injectables Market Forecast, by Treatment 13.16.1. Facial Pain 13.16.2. Wrinkle Treatment 13.16.3. Acne scar treatment 13.16.4. Lip Augmentation 13.16.5. Lipoatrophy treatment 13.16.6. Others (chin augmentation and Earlobe rejuvenation) 13.17. India Facial injectables Market Forecast, by End-use 13.17.1. Hospitals, 13.17.2. Ambulatory Surgical Centers, 13.17.3. Cosmetic Centers, 13.17.4. Dermatology Clinics, 13.17.5. Physician Clinics 13.18. Japan Facial injectables Market Forecast, by Type 13.18.1. Collagen 13.18.2. Hyaluronic Acid (HA) 13.18.3. Botulinum Toxin Type A 13.18.4. Calcium Hydroxylapatite (CaHA) 13.18.5. Polymer Fillers 13.19. Japan Facial injectables Market Forecast, by Treatment 13.19.1. Facial Pain 13.19.2. Wrinkle Treatment 13.19.3. Acne scar treatment 13.19.4. Lip Augmentation 13.19.5. Lipoatrophy treatment 13.19.6. Others (chin augmentation and Earlobe rejuvenation) 13.20. Japan Facial injectables Market Forecast, by End-use 13.20.1. Hospitals, 13.20.2. Ambulatory Surgical Centers, 13.20.3. Cosmetic Centers, 13.20.4. Dermatology Clinics, 13.20.5. Physician Clinics 13.21. ASEAN Facial injectables Market Forecast, by Type 13.21.1. Collagen 13.21.2. Hyaluronic Acid (HA) 13.21.3. Botulinum Toxin Type A 13.21.4. Calcium Hydroxylapatite (CaHA) 13.21.5. Polymer Fillers 13.22. ASEAN Facial injectables Market Forecast, by Treatment 13.22.1. Facial Pain 13.22.2. Wrinkle Treatment 13.22.3. Acne scar treatment 13.22.4. Lip Augmentation 13.22.5. Lipoatrophy treatment 13.22.6. Others (chin augmentation and Earlobe rejuvenation) 13.23. ASEAN Facial injectables Market Forecast, by End-use 13.23.1. Hospitals, 13.23.2. Ambulatory Surgical Centers, 13.23.3. Cosmetic Centers, 13.23.4. Dermatology Clinics, 13.23.5. Physician Clinics 13.24. Rest of Asia Pacific Facial injectables Market Forecast, by Type 13.24.1. Collagen 13.24.2. Hyaluronic Acid (HA) 13.24.3. Botulinum Toxin Type A 13.24.4. Calcium Hydroxylapatite (CaHA) 13.24.5. Polymer Fillers 13.25. Rest of Asia Pacific Facial injectables Market Forecast, by Treatment 13.25.1. Facial Pain 13.25.2. Wrinkle Treatment 13.25.3. Acne scar treatment 13.25.4. Lip Augmentation 13.25.5. Lipoatrophy treatment 13.25.6. Others (chin augmentation and Earlobe rejuvenation) 13.26. Rest of Asia Pacific Facial injectables Market Forecast, by End-use 13.26.1. Hospitals, 13.26.2. Ambulatory Surgical Centers, 13.26.3. Cosmetic Centers, 13.26.4. Dermatology Clinics, 13.26.5. Physician Clinics 13.27. Asia Pacific Facial injectables Market Attractiveness Analysis 13.27.1. By Type 13.27.2. By Treatment 13.27.3. By End-use 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Facial injectables Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Facial injectables Market Overview 14.3. Middle East & Africa Facial injectables Market Value Share Analysis, by Type 14.4. Middle East & Africa Facial injectables Market Forecast, by Type 14.4.1. Collagen 14.4.2. Hyaluronic Acid (HA) 14.4.3. Botulinum Toxin Type A 14.4.4. Calcium Hydroxylapatite (CaHA) 14.4.5. Polymer Fillers 14.5. Middle East & Africa Facial injectables Market Value Share Analysis, by Treatment 14.6. Middle East & Africa Facial injectables Market Forecast, by Treatment 14.6.1. Facial Pain 14.6.2. Wrinkle Treatment 14.6.3. Acne scar treatment 14.6.4. Lip Augmentation 14.6.5. Lipoatrophy treatment 14.6.6. Others (chin augmentation and Earlobe rejuvenation) 14.7. Middle East & Africa Facial injectables Market Value Share Analysis, by End-use 14.8. Middle East & Africa Facial injectables Market Forecast, by End-use 14.8.1. Hospitals, 14.8.2. Ambulatory Surgical Centers, 14.8.3. Cosmetic Centers, 14.8.4. Dermatology Clinics, 14.8.5. Physician Clinics 14.9. Middle East & Africa Facial injectables Market Value Share Analysis, by Country 14.10. Middle East & Africa Facial injectables Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Facial injectables Market Analysis, by Country 14.12. GCC Facial injectables Market Forecast, by Type 14.12.1. Collagen 14.12.2. Hyaluronic Acid (HA) 14.12.3. Botulinum Toxin Type A 14.12.4. Calcium Hydroxylapatite (CaHA) 14.12.5. Polymer Fillers 14.13. GCC Facial injectables Market Forecast, by Treatment 14.13.1. Facial Pain 14.13.2. Wrinkle Treatment 14.13.3. Acne scar treatment 14.13.4. Lip Augmentation 14.13.5. Lipoatrophy treatment 14.13.6. Others (chin augmentation and Earlobe rejuvenation) 14.14. GCC Facial injectables Market Forecast, by End-use 14.14.1. Hospitals, 14.14.2. Ambulatory Surgical Centers, 14.14.3. Cosmetic Centers, 14.14.4. Dermatology Clinics, 14.14.5. Physician Clinics 14.15. South Africa Facial injectables Market Forecast, by Type 14.15.1. Collagen 14.15.2. Hyaluronic Acid (HA) 14.15.3. Botulinum Toxin Type A 14.15.4. Calcium Hydroxylapatite (CaHA) 14.15.5. Polymer Fillers 14.16. South Africa Facial injectables Market Forecast, by Treatment 14.16.1. Facial Pain 14.16.2. Wrinkle Treatment 14.16.3. Acne scar treatment 14.16.4. Lip Augmentation 14.16.5. Lipoatrophy treatment 14.16.6. Others (chin augmentation and Earlobe rejuvenation) 14.17. South Africa Facial injectables Market Forecast, by End-use 14.17.1. Hospitals, 14.17.2. Ambulatory Surgical Centers, 14.17.3. Cosmetic Centers, 14.17.4. Dermatology Clinics, 14.17.5. Physician Clinics 14.18. Rest of Middle East & Africa Facial injectables Market Forecast, by Type 14.18.1. Collagen 14.18.2. Hyaluronic Acid (HA) 14.18.3. Botulinum Toxin Type A 14.18.4. Calcium Hydroxylapatite (CaHA) 14.18.5. Polymer Fillers 14.19. Rest of Middle East & Africa Facial injectables Market Forecast, by Treatment 14.19.1. Facial Pain 14.19.2. Wrinkle Treatment 14.19.3. Acne scar treatment 14.19.4. Lip Augmentation 14.19.5. Lipoatrophy treatment 14.19.6. Others (chin augmentation and Earlobe rejuvenation) 14.20. Rest of Middle East & Africa Facial injectables Market Forecast, by End-use 14.20.1. Hospitals, 14.20.2. Ambulatory Surgical Centers, 14.20.3. Cosmetic Centers, 14.20.4. Dermatology Clinics, 14.20.5. Physician Clinics 14.21. Middle East & Africa Facial injectables Market Attractiveness Analysis 14.21.1. By Type 14.21.2. By Treatment 14.21.3. By End-use 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Facial injectables Market Analysis 15.1. Key Findings 15.2. South America Facial injectables Market Overview 15.3. South America Facial injectables Market Value Share Analysis, by Type 15.4. South America Facial injectables Market Forecast, by Type 15.4.1. Collagen 15.4.2. Hyaluronic Acid (HA) 15.4.3. Botulinum Toxin Type A 15.4.4. Calcium Hydroxylapatite (CaHA) 15.4.5. Polymer Fillers 15.5. South America Facial injectables Market Value Share Analysis, by Treatment 15.6. South America Facial injectables Market Forecast, by Treatment 15.6.1. Facial Pain 15.6.2. Wrinkle Treatment 15.6.3. Acne scar treatment 15.6.4. Lip Augmentation 15.6.5. Lipoatrophy treatment 15.6.6. Others (chin augmentation and Earlobe rejuvenation) 15.7. South America Facial injectables Market Value Share Analysis, by End-use 15.8. South America Facial injectables Market Forecast, by End-use 15.8.1. Hospitals, 15.8.2. Ambulatory Surgical Centers, 15.8.3. Cosmetic Centers, 15.8.4. Dermatology Clinics, 15.8.5. Physician Clinics 15.9. South America Facial injectables Market Value Share Analysis, by Country 15.10. South America Facial injectables Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Facial injectables Market Analysis, by Country 15.12. Brazil Facial injectables Market Forecast, by Type 15.12.1. Collagen 15.12.2. Hyaluronic Acid (HA) 15.12.3. Botulinum Toxin Type A 15.12.4. Calcium Hydroxylapatite (CaHA) 15.12.5. Polymer Fillers 15.13. Brazil Facial injectables Market Forecast, by Treatment 15.13.1. Facial Pain 15.13.2. Wrinkle Treatment 15.13.3. Acne scar treatment 15.13.4. Lip Augmentation 15.13.5. Lipoatrophy treatment 15.13.6. Others (chin augmentation and Earlobe rejuvenation) 15.14. Brazil Facial injectables Market Forecast, by End-use 15.14.1. Hospitals, 15.14.2. Ambulatory Surgical Centers, 15.14.3. Cosmetic Centers, 15.14.4. Dermatology Clinics, 15.14.5. Physician Clinics 15.15. Mexico Facial injectables Market Forecast, by Type 15.15.1. Collagen 15.15.2. Hyaluronic Acid (HA) 15.15.3. Botulinum Toxin Type A 15.15.4. Calcium Hydroxylapatite (CaHA) 15.15.5. Polymer Fillers 15.16. Mexico Facial injectables Market Forecast, by Treatment 15.16.1. Facial Pain 15.16.2. Wrinkle Treatment 15.16.3. Acne scar treatment 15.16.4. Lip Augmentation 15.16.5. Lipoatrophy treatment 15.16.6. Others (chin augmentation and Earlobe rejuvenation) 15.17. Mexico Market Forecast, by End-use 15.17.1. Hospitals, 15.17.2. Ambulatory Surgical Centers, 15.17.3. Cosmetic Centers, 15.17.4. Dermatology Clinics, 15.17.5. Physician Clinics 15.18. Rest of South America Facial injectables Market Forecast, by Type 15.18.1. Collagen 15.18.2. Hyaluronic Acid (HA) 15.18.3. Botulinum Toxin Type A 15.18.4. Calcium Hydroxylapatite (CaHA) 15.18.5. Polymer Fillers 15.19. Rest of South America Facial injectables Market Forecast, by Treatment 15.19.1. Facial Pain 15.19.2. Wrinkle Treatment 15.19.3. Acne scar treatment 15.19.4. Lip Augmentation 15.19.5. Lipoatrophy treatment 15.19.6. Others (chin augmentation and Earlobe rejuvenation)d 15.20. Rest of South America Facial injectables Market Forecast, by End-use 15.20.1. Hospitals, 15.20.2. Ambulatory Surgical Centers, 15.20.3. Cosmetic Centers, 15.20.4. Dermatology Clinics, 15.20.5. Physician Clinics 15.21. South America Facial injectables Market Attractiveness Analysis 15.21.1. By Type 15.21.2. By Treatment 15.21.3. By End-use 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Bloomage BioTechnology Corporation Limited 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Ipsen Group, 16.3.3. Allergan Plc, 16.3.4. Prollenium Medical Technologies Inc., 16.3.5. Galderma S.A. (Nestle), and 16.3.6. Merz Pharma & Co. KGaA. 16.3.7. Advanced Dermatology 16.3.8. ColBar LifeScience Ltd., , 16.3.9. Valeant Pharmaceuticals North America LLC, 16.3.10. Sano Biosurgery Inc., 16.3.11. Anika Therapeutics, Inc. 16.3.12. Suneva Medical, Inc 16.3.13. Ipsen 16.3.14. Integra Lifesciences 16.3.15. Tei Biosciences 16.3.16. Fibrogen 16.3.17. Ethicon 17. Primary Key Insights

About This Report

Report ID36865
Category Healthcare
Published DateNov 2019
No of Pages183
Contact Us
Call Now